Humacyte, Inc.
HUMA
$1.47
-$0.03-2.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -2.85% | 2.94% | 15.74% | 23.55% | 19.45% |
| Gross Profit | 3.82% | -2.29% | -15.74% | -23.55% | -19.50% |
| SG&A Expenses | 32.65% | 39.82% | 26.53% | 20.51% | 13.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.84% | 10.41% | 18.01% | 22.88% | 18.16% |
| Operating Income | -4.07% | -9.90% | -18.01% | -22.88% | -18.21% |
| Income Before Tax | 58.00% | 26.52% | -34.24% | -71.01% | -57.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 58.00% | 26.52% | -34.24% | -71.01% | -57.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.00% | 26.52% | -34.24% | -71.01% | -57.49% |
| EBIT | -4.07% | -9.90% | -18.01% | -22.88% | -18.21% |
| EBITDA | -4.29% | -10.91% | -20.16% | -26.01% | -21.20% |
| EPS Basic | 65.29% | 33.34% | -17.93% | -54.99% | -47.09% |
| Normalized Basic EPS | 25.49% | 17.76% | -3.03% | -15.09% | -13.70% |
| EPS Diluted | 65.17% | 32.59% | -18.35% | -55.51% | -47.61% |
| Normalized Diluted EPS | 25.51% | 17.77% | -3.03% | -15.09% | -13.70% |
| Average Basic Shares Outstanding | 22.78% | 18.76% | 14.54% | 9.00% | 5.25% |
| Average Diluted Shares Outstanding | 22.84% | 18.82% | 14.54% | 9.00% | 5.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |